can semaglutide affect the liver targets MASH molecular pathways beyond weight loss Wegovy Treated Severe Liver Disease

Patient safety is Lillys top priority, and we actively engage in monitoring, evaluating, and reporting safety information for all our medicines

Patients receiving GLP-1 therapy demonstrated lower rates of advanced adenomas on surveillance colonoscopy, a finding particularly relevant given that adenoma prevention formed the evidentiary backbone for aspirins adoption in earlier prevention strategies

L- , , ,

As you lose weight, your metabolic rate decreases, potentially requiring a lower levothyroxine dose to maintain normal thyroid levels

GLP1RAs significantly decreased E-wave velocity, E/A ratio, E/e _ ratio, and EDT but did not affect LVEF